*ST 輔仁(600781.SH)控股股東1440萬股被司法拍賣及完成過户
格隆匯8月3日丨*ST輔仁(600781.SH)公佈,公司近日通過中國證券登記結算有限責任公司上海分公司系統查詢,獲知控股股東輔仁集團被司法拍賣的1440萬股股份已完成過户登記手續。本次股權過户完成後不會導致公司控股股東或實際控制人發生變化。
截止目前,輔仁集團逾期債務估計約38.45億元。因逾期債務,輔仁集團面臨多起訴訟,訴訟涉及金額約38億元,具體金額尚需進一步核實。
截止目前,公司償還所欠控股股東及其關聯方款項後,向控股股東及關聯方提供借款餘額16.36億元;公司向控股股東及關聯方提供連帶責任擔保1.4億元,尚有擔保餘額5980.00萬元。上述事項構成關聯方資金佔用及違規擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.